Evidence map›Paper›PMID 23714425›Full record

ArticleBiophysical chemistry2013

Heat-induced fibrillation of BclXL apoptotic repressor.

Vikas Bhat, Max B Olenick, Brett J Schuchardt, David C Mikles, Brian J Deegan, Caleb B McDonald, Kenneth L Seldeen, Dmitry Kurouski, Mohd Hafeez Faridi, Mohammed M Shareef and 3 more

Abstract read
In one paragraph

Article in Biophysical chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Vikas BhatDepartment of Biochemistry & Molecular Biology, Leonard Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
Max B Olenick
Brett J Schuchardt
David C Mikles
Brian J Deegan
Caleb B McDonald
Kenneth L Seldeen
Dmitry Kurouski
Mohd Hafeez Faridi
Mohammed M Shareef
Vineet Gupta
Igor K Lednev
Amjad Farooq

Funding

Translating oral CD11b agonist as a novel therapeutic for lupus nephritisR01DK084195 · NIDDK · UNIVERSITY OF TEXAS MED BR GALVESTON · PI VINEET GUPTA, Timothy B Niewold · 2011 to 2026
$5.7M
Leukadherins as novel compounds for treating restenosisR01HL109582 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI GUPTA, VINEET, VAZQUEZ PADRON, ROBERTO IRENARDO · 2012 to 2015
$1.7M
Structural and Functional Studies of the Novel DBD Domain of MKP5R01GM083897 · NIGMS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI FAROOQ, AMJAD · 2008 to 2012
$1.6M
Training in Translational Breast Cancer ResearchT32CA119929 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI SLINGERLAND, JOYCE MARIE · 2007 to 2011
$1.4M
Structural Characterization of Amyloid Fibrils Using Deep UV Raman SpectroscopyR01AG033719 · NIA · STATE UNIVERSITY OF NEW YORK AT ALBANY · PI LEDNEV, IGOR K · 2010 to 2014
$1.0M
NCI NIH HHS T32 CA119929NCI NIH HHS T32-CA119929NHLBI NIH HHS R01 HL109582NIA NIH HHS R01 AG033719NIA NIH HHS R01-AG033719NIDDK NIH HHS R01 DK084195NIDDK NIH HHS R01-DK084195NIGMS NIH HHS R01 GM083897NIGMS NIH HHS R01-GM083897
6 · The paper itself

Abstract

The BclXL apoptotic repressor bears the propensity to associate into megadalton oligomers in solution, particularly under acidic pH. Herein, using various biophysical methods, we analyze the effect of temperature on the oligomerization of BclXL. Our data show that BclXL undergoes irreversible aggregation and assembles into highly-ordered rope-like homogeneous fibrils with length in the order of mm and a diameter in the μm-range under elevated temperatures. Remarkably, the formation of such fibrils correlates with the decay of a largely α-helical fold into a predominantly β-sheet architecture of BclXL in a manner akin to the formation of amyloid fibrils. Further interrogation reveals that while BclXL fibrils formed under elevated temperatures show no observable affinity toward BH3 ligands, they appear to be optimally primed for insertion into cardiolipin bicelles. This salient observation strongly argues that BclXL fibrils likely represent an on-pathway intermediate for insertion into mitochondrial outer membrane during the onset of apoptosis. Collectively, our study sheds light on the propensity of BclXL to form amyloid-like fibrils with important consequences on its mechanism of action in gauging the apoptotic fate of cells in health and disease.

Indexed as

Hot TemperatureApoptosisbcl-X ProteinCardiolipinsCrystallography, X-RayHumansLigandsModels, MolecularProtein Structure, SecondaryBCL2L1 protein, humanbcl-X ProteinCardiolipinsLigands1,1′,2,2′-Tetraoleoyl cardiolipin (1′,3′-bis[1,2-dioleoyl-sn-glycero-3-phospho]-sn-glycerol)1,2-Dihexanoyl-sn-glycero-3-phosphocholine20-mer peptide derived from the BH3 domain of Bid8-Anilinonaphthalene-1-sulfonateALSAmyloid fibrilsAnalytical light scatteringANSBadBakBaxB-cell lymphoma 2B-cell lymphoma extra largeBcl2Bcl2-associated death (promoter)Bcl2-associated X (protein)Bcl2 (homologous) antagonist/killerBcl2 homology 1 (domain)Bcl2 homology 2 (domain)Bcl2 homology 3 (domain)Bcl2 homology 4 (domain)BclXLBclXL homodimer in which the TM domain of one monomer occupies the canonical hydrophobic groove within the other monomer and vice versa in a domain-swapped trans-fashionBclXL_transTMBH1BH2BH3BH3-interacting domain (death agonist)BH4BidBid_BH3CDCircular dichroismDHPCDLSDynamic light scatteringFluorescence microscopyFMIrreversible aggregationIsothermal titration calorimetryITCKinetic trapLICLigation-independent cloningMDMembrane insertionmitochondrial outer membraneMMMolecular dynamicsMolecular modelingMOMMyrmyricetinSECSize-exclusion chromatographySLSSSFStatic light scatteringSteady-state fluorescenceThioflavin TThTTMAOTOCLtrimethylamine N-oxideα–β structural transition

Identifiers

PMID23714425
PMCPMC3706518

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.